Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Intestinal Bacterial ${\beta}-Glucuronidase$ Activity of Patients with Colon Cancer

  • Published : 2001.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

The fecal ${\beta}-glucuronidase$ activity of patients with colon cancer and healthy controls were measured to determine the relationship between the fluctuation of intestinal bacterial ${\beta}-glucuronidase$ and colon cancer. The fecal ${\beta}-glucuronidase$ activity of patients with colon cancer was 1.7 times higher than that of the healthy controls. However, when these fecal specimens were sonicated, the enzyme activity of patients with colon cancer was 12.1 times higher than that of the healthy controls. The fecal ${\beta}-glucuronidase$ activity of human Intestinal bacteria was drastically induced by its substrate or the bile secreted after a subcutaneous injection of 1,2-dimethylhydrazine (DMH) and benzo[a]pyrene into rats. DMH-and benzo[a]pyrene-treated biles induced ${\beta}-glucuronidase$ activity in the human intestinal microflora by approximately 1.5- and 2.3-fold, respectively. They also induced ${\beta}-glucuronidase$ in E. coli HGU-3, which is a ${\beta}-glucuronidase$-producing bacterium from the human intestine. D-saccharic acid 1,4-lactone similarly inhibited fecal ${\beta}-glucuronidase$ in several patients with colon cancer in addition to the healthy controls. This suggests that potent ${\beta}-glucuronidase$ activity is a prime factor in the etiology of colon cancer.

Keywords

References

  1. Cancer v.36 Investigations into the metabolism and mode of action of the colon carcinogen 1,2-dimethylhydrazine Fiala,E.S.
  2. Cancer v.40 Investigation into the metabolism and mode of action of the colon carcinogen 1,2-dimethylhydrazine and azoxymethance Fiala,E.S.
  3. J. Natl. Cancer ints. v.57 The relationship between diet and rat fecal bacterial enzymes implicated in colon cancer Goldin,B;Gorbach,S.L.
  4. Cancer Res. v.35 Metabolic epidemiology of dietary factors in large bowel cancer Hill,M.J.
  5. Biol. Pharm. Bull. v.17 Characterization of β-glucosidase and β-glucuronidase of alkalotolerant intestinal bacteria Kim,D.H.;Kang,H.J.;Park,S.H.;Kobashi,K.
  6. Arch. Pharm. Res. v.18 Protective roles of mushrooms in experimental colon carcinogenesis Kim,D.H.;Jang,I.S.;Park,J.B.;Lee,S.W.
  7. Cancer Res. v.48 Aberrant Crypts: potential preneoplastic lesions in the murine colon McLellan,E.A.;Bird,R.P.
  8. Cancer Res. v.35 Colon carcinogensis with azoxymethane and dimethylhydrazine in germfree Reddy,B.S.;Narisawa,T.;Wright,P.;Vukusich,D.;Weiburger,J.H.;Wynder,E.L.
  9. J. Nutr. v.105 Effects of high risk and low risk diets for colon carcinogenesis on fecal microflora and stertoids in man Reddy,B.S.;Weiburger,J.H.;Wynder,E.L.
  10. Lancet v.16 High colonic pH promotes colorectal cancer Thorton J.R.
  11. Cancer v.28 Colon carcinogens and their mode of action Weiburger,J.H.
  12. Cancer v.40 Colon cancer: its epidemiology and experimental production Weiburger,J.H.;Reddy,B.S.;Wynder,E.L.
  13. Cancer v.34 Metabolic epidemiology of colorectal cancer Wynder,E.L.;Reddy,B.S.